Departments and Services | For Patients | Research & Trials | Education | Find a Doctor

Division of Infectious Disease
Division of Infections Disease
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Botswana-UPenn Partnership
Adjunct Faculty
Administrative Contacts
Outpatient Clinics


faculty photo

Karam C. Mounzer, MD

Clinical Associate Professor of Medicine
Attending Physician, Penn Presbyterian Medical Center
Department: Medicine

Contact information
Philadelphia Fight, 1233 Locust Street
Philadelphia, PA 19107
Office: 215-790-1788
Fax: 215-732-5490
Bachelor (Experimental Sciences and French Literature)
College Notre Dame de Jamhour, Beirut, Lebanon, 1985.
MD (Pre-Med & Med combined)
Saint Joseph University, Faculty of Medicine, Beirut, Lebanon , 1992.
Post-Graduate Training
Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 1992-1993.
Residency, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1993-1995.
Infectious Diseases Fellowship, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1995-1997.
Diplomate, American Board of Internal Medicine , 1995.
Diplomate, American Board of Infectious Diseases , 1997.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical Development of new antiretroviral agents

Description of Clinical Expertise

Treatment of Multi drug Resistant HIV virus, HIV-HCV co-infection

Description of Other Expertise

Suboxone Clinic for HIV infected opioid-addicted patients

Selected Publications

Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, Mounzer K, Samuel R, Metlay JP, Yehia BR: Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. AIDS Care Page: 1-12, February 2015.

Papasavvas E, Foulkes A, Yin X, Joseph J, Ross B, Azzoni L, Kostman JR, Mounzer K, Shull J, Montaner LJ: PDC and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in Chronically Suppressed HIV-1+ Subjects. Immunology Page: 12452, February 2015.

Patro S, Pal S, Bi Y, Lynn K, Mounzer K, Kostman J, Davuluri R, Montaner LJ: Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-related ISG/Bcl2-family Gene Expression in Chronic HIV-1 Infected Subjects Journal of Virology 89(1): 799-810, January 2015.

Castagna A, Maggiolo F, Penco G, Wright D, Mills A,Grossberg R, Molina JM, Chas J, Durant J, Moreno S, Doroana M, Ait-Khaled M, Huang J, Min S,Song I, Vavro C, Nichols G, Yeo JM, for the VIKING-3 Study Group (72 collaborators) Aberg J, Akil B, Arribas JR, Baril JG, Blanco Arévalo JL, Blanco Quintana F, Blick G, Boix Martínez V, Bouchaud O, Branco T, Bredeek UF, Castro Iglesias M, Clumeck N, Conway B, DeJesus E, Delassus JL, De Truchis P, Di Perri G, Di Pietro M, Duggan J, Duvivier C, Elion R, Eron J, Fish D, Gathe J, Haubrich R, Henderson H, Hicks C, Hocqueloux L, Hodder S, Hsiao CB, Katlama C, Kozal M, Kumar P, Lalla-Reddy S, Lazzarin A, Leoncini F, Llibre JM, Mansinho K, Morlat P, Mounzer K: Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study J Infect Dis Page: 354-62, August 2014.

Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D; PHOTON-1 Investigators: Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA 4: 353-61, July 2014.

Tomescu C, Liu Q, Ross BN1, Yin X, Lynn K, Mounzer K, Kostman JR, Montaner LJ: A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers PLoS One 9: e103209, July 2014.

Smith S, Mounzer K: Isolated hepatitis B surface antigenemia in an HIV-1-positive individual. AIDS Page: 1375-6, June 2014.

Yehia BR, Stewart L, Momplaisir F, Moody A, Holtzman C, Jacobs L, Hines J, Mounzer K, Glanz K, Metlay JP, Shea JA: Mapping Barriers to Retention in HIV Care and ART Adherence to Andersen’s Behavioral Model 9th International Conference on HIV Treatment and Prevention Adherence June 2014.

Hafkin JS, Osborn MK, Localio AR, Amorosa VK, Kostman JR, Stern JJ, De La Torre P, Mounzer K, Frank I, Gross R, Chang KM, Lo Re V 3rd: Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. J Viral Hepat Page: 288-96, April 2014.

Momplaisir F, Mounzer K, Long JA: Preventive cancer screening practices in HIV-positive patients. AIDS Care Page: 87-94, January 2014.

back to top
Last updated: 05/04/2015
The Trustees of the University of Pennsylvania